Become a Patron!

Genscript Reports Promising CARVYKTI® Trial Results

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
Genscript Reports Promising CARVYKTI® Trial Results


Genscript Biotech (HK:1548) has released an update. Genscript Biotech Corporation’s subsidiary, Legend Biotech, has announced promising results fro...

#genscriptbiotech #legendbiotech

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top